Morgan Keegan Reiterates Outperform on Health Care REIT (HCN)


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Morgan Keegan is out with a research report this morning, where it reiterates its Outperform rating on Health Care REIT (NYSE: HCN); it has a $52.00 price target on the stock, up from $51.00. The MK analysts recently adjusted the earnings model for HCN, which modestly raise revenue projections, but have no impact on FFO and FAD. Their 2010 estimates remain $3.19 and $2.95, respectively. Their 2011 estimates remain$3.35 and $3.08, respectively. The analysts believe that management's goal of 5% NOI growth from its joint venture is reasonable. In its RIDEA joint venture with Merrill Gardens, the rentsHealth Care REIT will forgo on the 13 facilities is contributing to the venture, and its acquisition pace.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsFinancialsMorgan KeeganSpecialized REIT's